Grant Street Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $839K | Buy |
4,522
+144
| +3% | +$26.7K | 0.19% | 30 |
|
|
2025
Q1 | $917K | Sell |
4,378
-1,420
| -24% | -$297K | 0.22% | 29 |
|
|
2024
Q4 | $1.03M | Buy |
5,798
+2,247
| +63% | +$399K | 0.27% | 30 |
|
|
2024
Q3 | $701K | Buy |
3,551
+20
| +0.6% | +$3.95K | 0.21% | 33 |
|
|
2024
Q2 | $606K | Hold |
3,531
| – | – | 0.19% | 35 |
|
|
2024
Q1 | $643K | Buy |
3,531
+2
| +0.1% | +$364 | 0.21% | 32 |
|
|
2023
Q4 | $547K | Buy |
3,529
+30
| +0.9% | +$4.65K | 0.19% | 32 |
|
|
2023
Q3 | $522K | Sell |
3,499
-71
| -2% | -$10.6K | 0.21% | 31 |
|
|
2023
Q2 | $481K | Buy |
3,570
+54
| +2% | +$7.28K | 0.18% | 34 |
|
|
2023
Q1 | $560K | Hold |
3,516
| – | – | 0.23% | 29 |
|
|
2022
Q4 | $568K | Hold |
3,516
| – | – | 0.25% | 28 |
|
|
2022
Q3 | $472K | Hold |
3,516
| – | – | 0.21% | 33 |
|
|
2022
Q2 | $538 | Buy |
3,516
+1,148
| +48% | +$176 | 0.28% | 31 |
|
|
2022
Q1 | $384K | Sell |
2,368
-400
| -14% | -$64.9K | 0.21% | 28 |
|
|
2021
Q4 | $375K | Buy |
2,768
+400
| +17% | +$54.2K | 0.2% | 27 |
|
|
2021
Q3 | $255K | Hold |
2,368
| – | – | 0.15% | 31 |
|
|
2021
Q2 | $267K | Sell |
2,368
-103
| -4% | -$11.6K | 0.16% | 30 |
|
|
2021
Q1 | $267K | Hold |
2,471
| – | – | 0.15% | 32 |
|
|
2020
Q4 | $265K | Hold |
2,471
| – | – | 0.14% | 26 |
|
|
2020
Q3 | $216K | Hold |
2,471
| – | – | 0.13% | 30 |
|
|
2020
Q2 | $243K | Buy |
+2,471
| New | +$243K | 0.14% | 25 |
|